These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8528347)

  • 1. Progressively increased serum 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2 intoxication.
    Sato K; Emoto N; Toraya S; Tsushima T; Demura H; Tsuji N; Inaba S; Takeuchi A; Kobayashi T
    Endocr J; 1994 Aug; 41(4):329-37. PubMed ID: 8528347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased 1,25-(OH)2D2 concentration in a patient with malignancy-associated hypercalcemia receiving intravenous hyperalimentation inadvertently supplemented with vitamin D2.
    Sato K; Imaki T; Toraya S; Demura H; Tanaka M; Kasajima T; Takeuchi A; Kobayashi T
    Intern Med; 1993 Nov; 32(11):886-90. PubMed ID: 8012094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.
    Biancuzzo RM; Clarke N; Reitz RE; Travison TG; Holick MF
    J Clin Endocrinol Metab; 2013 Mar; 98(3):973-9. PubMed ID: 23386645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy.
    Markestad T; Aksnes L; Ulstein M; Aarskog D
    Am J Clin Nutr; 1984 Nov; 40(5):1057-63. PubMed ID: 6333810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
    Finch JL; Brown AJ; Slatopolsky E
    J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum.
    Mawer EB; Jones G; Davies M; Still PE; Byford V; Schroeder NJ; Makin HL; Bishop CW; Knutson JC
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2156-66. PubMed ID: 9626155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
    Erben RG; Bante U; Birner H; Stangassinger M
    Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 1 alpha-hydroxyvitamin D2 to activated dihydroxyvitamin D 2 metabolites decreases endogenous 1 alpha, 25-dihydroxyvitamin D 3 in rats and monkeys.
    Knutson JC; Hollis BW; LeVan LW; Valliere C; Gould KG; Bishop CW
    Endocrinology; 1995 Nov; 136(11):4749-53. PubMed ID: 7588202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol.
    Knutson JC; LeVan LW; Valliere CR; Bishop CW
    Biochem Pharmacol; 1997 Mar; 53(6):829-37. PubMed ID: 9113104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy.
    Hartwell D; Tjellesen L; Christiansen C; Rødbro P
    Acta Neurol Scand; 1989 Jun; 79(6):487-92. PubMed ID: 2551121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Oct; 51(4):823-9. PubMed ID: 6968318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin D2 and vitamin D3 on the serum concentrations of 1,25(OH)2D2, and 1,25(OH)2D3 in normal subjects.
    Hartwell D; Hassager C; Christiansen C
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):378-84. PubMed ID: 3039769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
    Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
    Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
    Sato K; Nohtomi K; Demura H; Takeuchi A; Kobayashi T; Kazama J; Ozawa H
    Bone; 1997 Jul; 21(1):57-64. PubMed ID: 9213008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of vitamin D2 metabolites by human CYP24A1.
    Li L; Tuckey RC
    J Steroid Biochem Mol Biol; 2023 Oct; 233():106368. PubMed ID: 37495192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2.
    DeLuca HF; Sicinski RR; Tanaka Y; Stern PH; Smith CM
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E402-6. PubMed ID: 2833108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.